PTC Therapeutics Balance Sheet
NASDAQ: PTCTHealth CareBiotechnology: Pharmaceutical PreparationsUSD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
PTC Therapeutics financial position
At the end of fiscal 2025, PTC Therapeutics reported total assets of $2.90 billion, up 70.0% from a year earlier against total liabilities of $3.10 billion. Shareholders' equity was negative at -$205.3 million, meaning liabilities exceed assets; this is often the result of large share buybacks or accumulated losses. The company held $984.6 million in cash and equivalents against $286.6 million of debt, a net cash position of $698.0 million.
The current ratio (current assets divided by current liabilities) was 2.35, meaning short-term assets cover obligations due within a year.
Summary generated from market data by MetaCap's automated system. Methodology
PTC Therapeutics balance sheet (annual)
| Fiscal year (USD) | FY 20252025-12-31 | FY 20242024-12-31 | FY 20232023-12-31 | FY 20222022-12-31 | FY 20212021-12-31 | FY 20202020-12-31 | FY 20192019-12-31 | FY 20182018-12-31 | FY 20172017-12-31 | FY 20162016-12-31 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | 984.65M | 779.71M | 594.00M | 279.83M | 189.72M | 208.81M | 288.03M | 169.50M | 111.79M | 58.32M |
| Short-Term Investments | 960.72M | 359.99M | 282.74M | 130.87M | 583.66M | 894.84M | 398.54M | 58.09M | 79.45M | 173.34M |
| Receivables | 181.62M | 158.55M | 160.82M | 155.61M | 110.45M | 69.93M | 55.54M | 67.91M | 40.39M | 24.93M |
| Inventory | 79.65M | 23.19M | 30.58M | 21.81M | 15.86M | 18.70M | 19.29M | 16.12M | 10.75M | 0 |
| Total Current Assets | 2.27B | 1.37B | 1.22B | 693.78M | 954.37M | 1.23B | 779.28M | 320.86M | 249.06M | 261.29M |
| Property, Plant & Equipment | 55.37M | 60.97M | 87.09M | 72.59M | 52.59M | 33.83M | 21.55M | 12.69M | 8.38M | 7.43M |
| Goodwill | 82.34M | 82.34M | 82.34M | 82.34M | 82.34M | 82.34M | 82.34M | 82.34M | 0 | — |
| Intangible Assets | 388.75M | 118.79M | 379.50M | 705.89M | 724.84M | 715.33M | 710.50M | 701.03M | 132.99M | 0 |
| Total Assets | 2.90B | 1.71B | 1.90B | 1.71B | 1.94B | 2.21B | 1.62B | 1.12B | 391.65M | 269.35M |
| Accounts Payable | 45.49M | 17.27M | 6.04M | 27.27M | 23.03M | 18.66M | 10.32M | 6.00M | 15.28M | 6.30M |
| Short-Term Debt | 286.63M | — | — | — | 149.54M | — | 20.00M | 11.67M | 0 | — |
| Total Current Liabilities | 968.43M | 580.98M | 603.10M | 406.24M | 509.35M | 277.33M | 235.86M | 166.80M | 82.05M | 49.62M |
| Long-Term Debt | — | 285.41M | 284.21M | 571.72M | 281.89M | 309.14M | 293.86M | 141.35M | 144.97M | 98.22M |
| Total Liabilities | 3.10B | 2.80B | 2.71B | 2.05B | 1.94B | 1.73B | 1.03B | 768.50M | 235.22M | 149.76M |
| Shareholders' Equity | -205.31M | -1.10B | -818.55M | -347.09M | 1.44M | 481.98M | 594.33M | 350.73M | 156.44M | 119.58M |
| Retained Earnings | -2.96B | -3.65B | -3.28B | -2.66B | -2.10B | -1.63B | -1.19B | -938.92M | -814.11M | -735.11M |
| Total Debt | 286.63M | 285.41M | 284.21M | 571.72M | 431.43M | 309.14M | 313.86M | 153.01M | 144.97M | 98.22M |
| Net Cash (Debt) | 1.66B | 854.28M | 592.53M | -161.02M | 341.94M | 794.50M | 372.70M | 74.57M | 46.27M | 133.45M |
| Shares Outstanding | 81.47M | 77.70M | 75.71M | 73.10M | 70.83M | 69.72M | 61.94M | 50.61M | 41.61M | 34.17M |
This table shows 10 annual periods of PTC Therapeutics's balance sheet, from FY 2025 back to FY 2016, across 19 line items including cash & equivalents, short-term investments, receivables. Values in USD; B = billions, M = millions. Fiscal periods follow PTCT's reporting calendar. What is a balance sheet?